Last reviewed · How we verify

NCT03957798

Evaluation of a Motion-Activated Refusal-Skills Training Video Game for Prevention of Substance Use Disorder Relapse

Completed NA Last updated 21 May 2019
What this trial tests

NA trial testing RecoveryWarrior 2.0 in Relapse in 80 participants. Completed in 31 October 2016.

Timeline
5 February 2016
Primary endpoint
21 June 2016
31 October 2016

Quick facts

Lead sponsorGeorge Washington University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date5 February 2016
Primary completion21 June 2016
Estimated completion31 October 2016

Drugs / interventions tested

Conditions studied

Sponsor

George Washington University

Who can join

Adults 15 to 25, any sex, with Relapse or Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project proposes to continue the development of an intervention for relapse prevention in the form of a professional quality video game which rewards drug-rejecting physical motions and spoken refusal phrases. Phase I research findings showed that youth in recovery experienced increased low craving levels, strong levels of satisfaction, and interest in attending treatment sessions where the intervention is available - an important outcome since failure to attend treatment is highly correlated with relapse. In Phase II, the investigators propose to modify and expand the prototype based on customer feedback from treatment centers, counselors and patients. The investigators will test the effectiveness of the motion and voice-controlled game in a randomized controlled trial of youths in treatment for opioid use disorder who have access to the game for a month. The investigators will measure the effect of gameplay on successful completion of detoxification/inpatient treatment and rates of linkage to next level of outpatient treatment. The investigators will also measure the effect of gameplay compared to treatment as usual (TAU) during a subsequent episode of outpatient treatment (following inpatient), on rates of treatment attendance, treatment retention, urine drug test results, substance use self-report, treatment alliance, drug craving, and treatment satisfaction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Motion-Activated Video Game for Prevention of Substance Use Disorder Relapse in Youth: Pilot Randomized Controlled Trial.
    Abroms LC, Fishman M, Vo H, Chiang SC, et al · · 2019 · cited 6× · PMID 31124471 · DOI 10.2196/11716

Verify or expand the search:

Other recruiting trials for Relapse

Currently open trials in the same condition.

Other George Washington University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing